Pathogenesis of Physical Induced Urticarial Syndromes
-
- STATUS
- Recruiting
-
- participants needed
- 400
-
- sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
Summary
- Background
-
- Urticaria is a common itchy skin disorder that may occur spontaneously or on exposure to a physical trigger (called physical urticaria).
- Researchers are studying the genetic basis of a physically induced urticarial syndrome. Once called familial cold urticaria, this condition is now called familial cold autoinflammatory syndrome (FCAS). FCAS is an autoinflammatory disease, a group of inherited disorders characterized by unprovoked episodes of inflammation. Patients with FCAS often have hives, joint pain, and fever following general exposure to cold.
- Patients with FCAS have a mutation in a gene that makes a protein called cryopyrin.
Cryopyrin seems to be involved with the production of a proinflammatory mediator called
interleukin-1 (IL-1). Patients with FCAS and others with autoinflammatory syndromes have
benefited from medication that blocks the effects of IL-1.
- Objectives
- To investigate mechanisms that may cause physical hives or urticaria.
- To reproduce urticaria through challenge testing (procedures to test the skin for a
reaction to a stimulus), followed by mast cell studies, measurement of IL-1, genetic
studies, and other molecular studies to lead to a better understanding of urticaria and
to design safe and more effective treatments.
- Eligibility
- Patients between 6 months and 65 years of age with a documented history of clinically reproducible physical urticaria that triggers hives and that has been evaluated by a physician. Patients should have a letter of referral, including copies of pertinent medical history and laboratory studies, from a referring physician.
- Affected and nonaffected family members of such patients.
- Exclusion criteria include (1) the presence of conditions that may put the subject at
undue risk, such as acute infection, severe thrombocytopenia (a lower than normal number
of platelets in the blood), or significant cardiovascular disease; (2) any condition
that would make the subject unsuitable for enrollment in this study; and (3) a history
of HIV, other known immunodeficiency, or evidence of chronic Hepatitis B and/or C
infection.
- Design
- Researchers will conduct the following tests to verify which triggers cause the hives:
- History and physical exam to determine the relationship between the trigger and appearance of the hives.
- Blood samples for baseline screening (additional samples may be taken within 8 hours of triggering hives).
- Verification of hives using standard challenge testing.
- Procedures to trigger urticaria (the challenge testing) include dermatographism (stroking the skin), delayed pressure urticaria (direct pressure), cold-induced urticaria (cold exposure), cholinergic urticaria (exercise, hot water), solar urticaria (sun exposure), localized heat urticaria (direct heat exposure), aquagenic urticaria (room temperature water), and vibratory angioedema (direct vibratory stimulus exposure).
- Participants who have a positive history for hives and failed challenge testing (that is, hives resulted from the triggers) will be asked to provide a skin biopsy and additional bloods samples for research purposes.
- Participants will be asked to return to the clinic within 1 month if multiple triggers could not be verified during the initial visit, or to return for additional research evaluations, which may include a skin punch biopsy and blood sample collection. Patients may have to stay at the hospital overnight, if required to document the disease.
- Nonaffected family members who enroll in this protocol will provide samples for comparison with the family member who has a history of hives.
- Participants will receive a small financial compensation for the skin biopsy.
Description
Urticaria is a common skin disorder that is classified according to its chronicity into acute and chronic forms. It may occur spontaneously or on exposure to a physical factor. In the latter case, the urticaria is classified as a physical urticaria . Physical urticaria may be induced by mechanical and applied pressure, exercise, or exposure to cold, heat, sun, water, or vibration. The urticarial lesions are generally thought to be the result of mast cell activation and degranulation, which is supported by the finding of increased levels of serum histamine during some urticarial flares. Passive transfer experiments, whereupon serum from affected donors is transferred into recipient s skin followed by physical stimulation with resultant urticaria at the site of challenge, have been positive in some instances. This suggests the presence of an intrinsic factor in serum, such as IgE, which then mediates activation of tissue mast cells. However, the pathogenesis in general remains unclear and a genetic basis for these disorders has not been elucidated.
The goal of this protocol is thus to gain a better understanding of the pathogenesis of physical urticaria through the investigation of subjects with severe and unusual phenotypes and/or inherited patterns of disease. Subjects will undergo a clinical evaluation that will include verification of their urticaria. Blood and tissue samples, if available, will be collected for analysis. The analysis will be targeted toward the determination of novel serum mediators, mast cell activation and mutational analysis in families with inherited patterns.
Details
| Condition | Hypersensitivity, Immediate, Autoinflammatory Syndromes, Physical Urticaria, Familial Cold Autoinflammatory Syndromes |
|---|---|
| Clinical Study Identifier | NCT00887939 |
| Sponsor | National Institute of Allergy and Infectious Diseases (NIAID) |
| Last Modified on | 20 June 2022 |
How to participate?
,
You have contacted , on
Your message has been sent to the study team at ,
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
Primary Contact
Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.
Learn moreIf you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Learn moreComplete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.
Learn moreSimilar trials to consider
Browse trials for
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteer